Losartan Potassium Tablet, Film Coated
Product Images NDC 68382-137

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68382-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C516a5a7 Cfc8 4b3b A8bc 7644c3313673 01

FDA Label Image

C516a5a7 Cfc8 4b3b A8bc 7644c3313673 02

This is a summary of a study showing the comparison of the effectiveness of Atenolol and Losartan Potassium in reducing the risk of the primary endpoint. Atenolol showed a risk reduction of 13% compared to Losartan Potassium. The study was conducted over a period of 66 months with measurements taken at various intervals.*

FDA Label Image

C516a5a7 Cfc8 4b3b A8bc 7644c3313673 03

This is a chart showing the percentage of patients who experienced either fatal or non-fatal stroke while taking Atenolol or Losartan Potassium. The chart displays adjusted risk reduction of 25% for Losartan Potassium with a p-value of 0.001. The study was conducted over a period of 66 months.*

FDA Label Image

C516a5a7 Cfc8 4b3b A8bc 7644c3313673 04

FDA Label Image

C516a5a7 Cfc8 4b3b A8bc 7644c3313673 05

This appears to be a table or graph showing the percentage of patients with an event and the risk reduction for Losartan Potassium tablets compared to a placebo. The table also shows a significant p-value of 0.022. However, without more context, it is difficult to provide a more detailed description or interpretation of the results.*

FDA Label Image

C516a5a7 Cfc8 4b3b A8bc 7644c3313673 06

This is a medication label for Losartan Potassium tablets, USP typically used for treating high blood pressure. Each bottle contains 30 tablets and has an NDC number of 68382-135-06. The dosage and usage instructions are not provided in the given text.*

FDA Label Image

C516a5a7 Cfc8 4b3b A8bc 7644c3313673 07

This is a description of a medication named "Potassium Tablets, USP". The format and presentation of the text is not clear. The medication is manufactured by "Zydus Ronty B" company and is available in 30 tablet form.*

FDA Label Image

C516a5a7 Cfc8 4b3b A8bc 7644c3313673 08

Losartan and Potassium Tablets, USP are a medication produced by Pramacautiss in the USA. Unfortunately, the text is fragmented and incomplete, making it difficult to provide any additional useful information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.